Clinical Trials Directory

Trials / Conditions / NPM1 Mutation

NPM1 Mutation

7 registered clinical trials studyying NPM1 Mutation — 5 currently recruiting.

StatusTrialSponsorPhase
Not Yet RecruitingObservational Study on APL-like aCute Myeloid Leukemia: disTInct Phenotype and Early VAscular complicaTions
NCT07080970
Gruppo Italiano Malattie EMatologiche dell'Adulto—
RecruitingPhase 2 Trial of BN104 as Post-HSCT Maintenance in Acute Leukemia
NCT07101497
The First Affiliated Hospital of Soochow UniversityPhase 2
RecruitingZiftomenib Maintenance Post Allo-HCT
NCT06440135
Massachusetts General HospitalPhase 1
RecruitingSafety and Tolerability of Ziftomenib Combinations in Patients With Relapsed/Refractory Acute Myeloid Leukemia
NCT06001788
Kura Oncology, Inc.Phase 1
Active Not RecruitingA Study of BN104 in the Treatment of Acute Leukemia
NCT06052813
Institut de Recherches Internationales Servier (I.R.I.S.)Phase 1 / Phase 2
RecruitingA Study to Investigate the Safety and Tolerability of Ziftomenib in Combination With Venetoclax/Azacitidine, V
NCT05735184
Kura Oncology, Inc.Phase 1
UnknownVenetoclax and Azacitidine for the Management of Molecular Relapse/Progression in Adult NPM1-mutated Acute Mye
NCT04867928
Gruppo Italiano Malattie EMatologiche dell'AdultoPhase 2